Publications
- Circulating tumor cells as a biomarker for the patients with castration resistant prostate cancerPublication without faculty affiliation
- Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?2024 | First Faculty of Medicine, Second Faculty of Medicine
- Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum2023 | First Faculty of Medicine, Second Faculty of Medicine
- Serum Thymidine Kinase 1 - Potential Prostate Cancer Biomarker: A Clinical Study2023 | First Faculty of Medicine, Second Faculty of Medicine
- Overview of serum markers of prostate cancer2023 | First Faculty of Medicine
- Prognostic factors in metastatic prostate cancer2023 | First Faculty of Medicine
- PSMA PET/CT in Primary Staging of High-risk Prostate Cancer2023 | First Faculty of Medicine
- European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update2023 | First Faculty of Medicine
- European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)2022 | First Faculty of Medicine, Second Faculty of Medicine
- T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum2022 | First Faculty of Medicine, Second Faculty of Medicine
Loading network view...